Portra/E+ via Getty Images
PolyPid (NASDAQ:PYPD) is an Israeli company focusing on the development, manufacturing, and commercialization of novel, locally administered therapies to improve surgical outcomes. Basis of PolyPid’s product candidates is a unique technology platform that is anchored in the surgical site to provide
Analyst’s Disclosure:I/we have a beneficial long position in the shares of PYPD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
This article was written in collaboration with BiotechProfSchleuning
BiotechProfSchleuning acts as an independent investment agency with a high degree of specialization on companies in the healthcare sector.BiotechProfSchleuning offers institutional investors and high net worth private clients exclusive partnerships for company investments.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
